Evidence map›Paper›PMID 31690986›Full record

ReviewDiabetologia2019

Extracellular vesicles in metabolic disease.

Naveed Akbar, Valerio Azzimato, Robin P Choudhury, Myriam Aouadi

Open access · hybridAbstract readReview
In one paragraph

Review in Diabetologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 1 synthesis or guideline pooled it, 177 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Insulin Resistance and Inflammation.International journal of molecular sciences · 2026
    Review
  11. Article
  12. Article
  13. The role of extracellular vesicles in kidney disease progression.Kidney research and clinical practice · 2026
    Article
  14. Article
  15. Article
  16. From Genome to Geroscience: How DNA Damage Shapes Systemic Decline.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Naveed AkbarDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK. Naveed.akbar@cardiov.ox.ac.uk.
Valerio AzzimatoIntegrated Cardio Metabolic Centre, Department of Medicine, Karolinska Institutet, NOVUM, Blickagången 6, 141 57, Huddinge, Sweden.
Robin P ChoudhuryDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Myriam AouadiIntegrated Cardio Metabolic Centre, Department of Medicine, Karolinska Institutet, NOVUM, Blickagången 6, 141 57, Huddinge, Sweden. Myriam.aouadi@ki.se.
University of Oxford · GBIntegrated Cardio Metabolic Centre · SEKarolinska Institutet · SE

Funding

British Heart Foundation PG/18/53/33895British Heart Foundation RE/13/1/30181
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are submicron-sized lipid envelopes that are produced and released from a parent cell and can be taken up by a recipient cell. EVs are capable of mediating cellular signalling by carrying nucleic acids, proteins, lipids and cellular metabolites between cells and organs. Metabolic dysfunction is associated with changes in plasma concentrations of EVs as well as alterations in their EV cargo. Since EVs can act as messengers between parent and recipient cells, they could be involved in cell-to-cell and organ-to-organ communication in metabolic diseases. Recent literature has shown that EVs are produced by cells within metabolic tissues, such as adipose tissue, pancreas, muscle and liver. These vesicles have therefore been proposed as a novel intercellular communication mode in systemic metabolic regulation. In this review, we will describe and discuss the current literature that investigates the role of adipose-derived EVs in the regulation of obesity-associated metabolic disease. We will particularly focus on the EV-dependent communication between adipocytes, the vasculature and immune cells in type 2 diabetes.

Indexed as

AdipocytesCell CommunicationDiabetes Mellitus, Type 2ExosomesExtracellular VesiclesHumansMacrophagesMetabolic DiseasesAdipocytesDiabetesDiagnosticEndothelial cellsExosomesExtracellular vesicleImmune cellsMacrophagesMetabolic dysfunctionPlateletsReviewTherapeutic

Identifiers

PMID31690986
PMCPMC6861353
OpenAlexW2984454355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.